Table 1 Clinical profile of the PC patients recruited in this study
| Â | Methylome group | P | Test group | P | |||
|---|---|---|---|---|---|---|---|
Pancreatic carcinoma | Non-tumor tissue adjacent to pancreatic carcinoma | Pancreatic carcinoma | Non-tumor tissue adjacent to pancreatic carcinoma | ||||
Number of patients | 10 | 10 | Â | 16 | 15 | Â | |
Sex | |||||||
| Â | Male | 6 (60.0%) | 6 (60.0%) | 1.000 | 12 (75.0%) | 12 (75.0%) | 0.638 |
| Â | Female | 4 (40.0%) | 4 (40.0%) | 4 (25.0%) | 4 (25.0%) | ||
Age | |||||||
| Â | >60Â years | 7 (70.0%) | 7 (70.0%) | 1.000 | 12 (75.0%) | 12 (80.0%) | 1.000 |
|  | ≤60 years | 3 (30.0% | 3 (30.0% | 4 (25.0%) | 3 (20.0%) | ||
Tumor location | |||||||
| Â | Head | 7 (70.0%) | 7 (70.0%) | 1.000 | 13 (71.2%) | 13 (86.7%) | 1.000 |
| Â | Body and tail | 3 (30.0% | 3 (30.0% | 3 (18.8%) | 2 (13.3%) | ||
Differentiation | |||||||
| Â | Poor | 4 (40.0%) | 4 (40.0%) | 1.000 | 3 (37.5%) | 1 (20.0%) | 1.000 |
| Â | Moderate | 6 (60.0%) | 6 (60.0%) | 5(63.5%) | 4 (80.0%) | ||
| Â | High | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
Tumor stage | |||||||
| Â | I, II | 7 (70.0%) | 7 (70.0%) | 1.000 | 6 (75.0%) | 4 (80.0%) | 1.000 |
| Â | III, IV | 3 (30.0%) | 3 (30.0%) | 2 (25.0%) | 1 (20.0%) | ||
Tumor size | |||||||
|  | ≤3 cm | 6 (60.0%) | 6 (60.0%) | 1.000 | 6 (75.0%) | 4 (80.0%) | 0.638 |
| Â | >3Â cm | 4 (40.0%) | 4 (40.0%) | 2 (25.0%) | 1 (20.0%) | ||
Lymph node metastasis | |||||||
| Â | Yes | 8 (80.0%) | 8 (80.0%) | 1.000 | 7 (87.5%) | 4 (80.0%) | 1.000 |
| Â | No | 2 (20.0%) | 2 (20.0%) | 1 (12.5%) | 1 (20.0%) | ||